Skip to main content

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Featured review: Learning from studying very rare cardiac conditions: the example of short QT syndrome

In this review, Hancox et al. make an imperative case to study rare conditions such as short QT syndrome (SQTS), a condition with rare genetic forms that may be underdiagnosed and carrying the risk of sudden death. The detailed study of SQTS is both directly beneficial for the treatment/management of affected patients and for increasing the understanding of associated underlying cardiac physiology and pharmacology. The pursuit of underlying gene mutations can lead to unanticipated new links between particular genes and cardiac electrophysiology, opening new avenues for research and potential therapeutic intervention.


Editorial Board

This position is currently vacant.

Associate Editors
Paul Clift, Queen Elizabeth Hospital, Birmingham, UK
Paolo Ferrero, Papa Giovanni XXIII Hospital, Italy
Jonathan R Skinner, Greenlane Paediatric and Congenital Heart Services, Starship Children's Hospital, Auckland, New Zealand
Robert Tulloh, Bristol Heart Institute and Bristol Royal Hospital for Children, UK
Orhan Uzun, University Hospital of Wales, UK

Editorial Board
Massimo Caputo, Bristol Heart Institute, UK
Shanta Chakrabarti, Vancouver Children's Hospital, Canada
Clifford Cua, Nationwide Childrens Hospital, United States 
Gerhard-Paul Diller, University Hospital Munster, Germany and Imperial College London, UK
Abdul Karim Duke, Sheikh Khalifa Medical City, United Arab Emirates
Giorgio Faganello, Centro Cardiovascolare, Trieste, Italy
Jonathan Forsey, Sydney Children's Hospital, Australia
Marcus Haw, Helen DeVos Children’s Hospital, Grand Rapids, Michigan, USA
Juan P Kaski, Great Ormond Street Hospital and University College London, UK
Damien P Kenny, Our Lady's Hospital for Sick Children, Ireland

Aims and scope

 Journal of Congenital Cardiology will cease to be published by BioMed Central as of December 31, 2021. BioMed Central will continue to host an archive of all articles previously published in the Journal. All articles published in Journal of Congenital Cardiology will remain fully searchable via the Biomed Central website.

Journal of Congenital Cardiology is an online journal publishing in all areas of congenital cardiology. Submissions are welcomed on all subspecialties including (but not limited to) genetics, epidemiology, electrophysiology and interventions.

The journal will publish expert reviews and latest research articles, short series and case reports may be also considered if they provide a unique or notable insight into the aetiology, diagnosis or management of a congenital heart condition.

By bringing together open-access research and knowledge published in these areas, Journal of Congenital Cardiology aims to provide an essential resource for cardiologists, surgeons, general practitioners, researchers and healthcare professionals interested in congenital heart disease.

Submit your manuscript!

Journal of Congenital Cardiology is now accepting submissions; please use the online submission system to submit your manuscript.


This position is currently vacant.

Annual Journal Metrics

  • Speed
    64 days to first decision for reviewed manuscripts only
    64 days to first decision for all manuscripts
    106 days from submission to acceptance
    37 days from acceptance to publication

    42 Altmetric Mentions